BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15114100)

  • 1. A novel monoclonal antibody inhibits the immune response of human cells against porcine cells: identification of a porcine antigen homologous to CD58.
    Crosby K; Yatko C; Dersimonian H; Pan L; Edge AS
    Transplantation; 2004 Apr; 77(8):1288-94. PubMed ID: 15114100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine CD58: cDNA cloning and molecular dissection of the porcine CD58-human CD2 interface.
    Brossay A; Hubé F; Moreau T; Bardos P; Watier H
    Biochem Biophys Res Commun; 2003 Oct; 309(4):992-8. PubMed ID: 13679072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution.
    Ikemizu S; Sparks LM; van der Merwe PA; Harlos K; Stuart DI; Jones EY; Davis SJ
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4289-94. PubMed ID: 10200255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulatory Function of Cd58/Cd2 Interaction in Adaptive Humoral Immunity in a Zebrafish Model.
    Shao T; Shi W; Zheng JY; Xu XX; Lin AF; Xiang LX; Shao JZ
    Front Immunol; 2018; 9():1204. PubMed ID: 29904386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.
    Arulanandam AR; Moingeon P; Concino MF; Recny MA; Kato K; Yagita H; Koyasu S; Reinherz EL
    J Exp Med; 1993 May; 177(5):1439-50. PubMed ID: 7683037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
    Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
    Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors.
    Wang JH; Smolyar A; Tan K; Liu JH; Kim M; Sun ZY; Wagner G; Reinherz EL
    Cell; 1999 Jun; 97(6):791-803. PubMed ID: 10380930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2.
    Somoza C; Driscoll PC; Cyster JG; Williams AF
    J Exp Med; 1993 Aug; 178(2):549-58. PubMed ID: 7688025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway.
    Albert-Wolf M; Meuer SC; Wallich R
    Int Immunol; 1991 Dec; 3(12):1335-47. PubMed ID: 1723296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multimeric form of soluble recombinant sheep LFA-3 (CD58) inhibits human T-cell proliferation.
    Yamashita K; Parish CR; Warren HS; Harrison LC
    Immunology; 1997 Sep; 92(1):39-44. PubMed ID: 9370922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a soluble form of CD58 in synovial fluid of patients with rheumatoid arthritis (RA).
    Hoffmann JC; Bayer B; Zeidler H
    Clin Exp Immunol; 1996 Jun; 104(3):460-6. PubMed ID: 9099931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous regulation of CD2 adhesion and signaling functions by a novel CD2 monoclonal antibody.
    van Kemenade FJ; Tellegen E; Maurice MM; Lankester AC; Kuijpers TW; Brouwer M; de Jong R; Miedema F; van Lier RA
    J Immunol; 1994 May; 152(9):4425-32. PubMed ID: 7512595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD58 Immunobiology at a Glance.
    Zhang Y; Liu Q; Yang S; Liao Q
    Front Immunol; 2021; 12():705260. PubMed ID: 34168659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells.
    Nielsen M; Gerwien J; Geisler C; Röpke C; Svejgaard A; Odum N
    Exp Clin Immunogenet; 1998; 15(2):61-8. PubMed ID: 9691200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based identification of inhibitors disrupting the CD2-CD58 interactions.
    Tripathi N; Leherte L; Vercauteren DP; Laurent AD
    J Comput Aided Mol Des; 2021 Mar; 35(3):337-353. PubMed ID: 33532888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD2-CD58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunity.
    Gollob JA; Ritz J
    Ann N Y Acad Sci; 1996 Oct; 795():71-81. PubMed ID: 8958918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Cellular Avidity Regulation in CD2-CD58-Mediated T Cell Adhesion.
    Zhu DM; Dustin ML; Cairo CW; Thatte HS; Golan DE
    ACS Chem Biol; 2006 Nov; 1(10):649-58. PubMed ID: 17168569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional epitopes of the human adhesion receptor CD58 (LFA-3).
    Dengler TJ; Hoffmann JC; Knolle P; Albert-Wolf M; Roux M; Wallich R; Meuer SC
    Eur J Immunol; 1992 Nov; 22(11):2809-17. PubMed ID: 1385151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory properties of soluble recombinant human CD58 (LFA-3) molecules.
    Albert-Wolf M; Meuer SC; Wallich R
    Dev Biol Stand; 1992; 77():87-92. PubMed ID: 1385237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.
    Kato K; Koyanagi M; Okada H; Takanashi T; Wong YW; Williams AF; Okumura K; Yagita H
    J Exp Med; 1992 Nov; 176(5):1241-9. PubMed ID: 1383383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.